Evaluation of immunotherapy response score (IRS) for predicting pembrolizumab (pembro) clinical benefit in patients (pts) with advanced solid tumors.

Authors :: Thomas, Sachdev P.
Achacoso, Ninah
Jiang, Chen
Chung, Elaine
Solorzano-Pinto, Aleyda V.
Tse, Pamela
Bulen, Benjamin J.
Khazanov, Nickolay A.
Lamb, Laura Elaine
Hovelston, Daniel H.
Kwiatkowski, Kat
Johnson, D. Bryan
Rhodes, Daniel R.
Tomlins, Scott A.
Suga, Jennifer Marie
Habel, Laurel A.
Source :: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pe14646-e14646, 1p
Publication Year :: 2023

Full Text Access

Tools